Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
2024年11月5日 - 6:15AM
ビジネスワイヤ(英語)
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that the company has scheduled the release
of its third quarter 2024 financial results after the market close
on Tuesday, November 12, 2024.
The company will hold a conference call at 4:30 p.m. Eastern on
Tuesday, November 12, which will remain open to the public. During
the conference call, the company will review its financial results
and provide business updates.
Participants should register for, and access, the call using
this link. While not required, it is recommended to join 10 minutes
prior to the event start. Once registered, participants will be
given the option to either dial into the call with the number and
unique passcode provided, or to use the dial-out option to connect
their phone instantly. The link to access the live webcast can also
be found on the Sangamo Therapeutics website in the Investors and
Media section under Events.
A replay will be available following the conference call,
accessible under Events.
About Sangamo Therapeutics
Sangamo Therapeutics is a genomic medicine company dedicated to
translating ground-breaking science into medicines that transform
the lives of patients and families afflicted with serious
neurological diseases who do not have adequate or any treatment
options. Sangamo believes that its zinc finger epigenetic
regulators are ideally suited to potentially address devastating
neurological disorders and that its capsid discovery platform can
expand delivery beyond currently available intrathecal delivery
capsids, including in the central nervous system. Sangamo’s
pipeline also includes multiple partnered programs and programs
with opportunities for partnership and investment. To learn more,
visit www.sangamo.com and connect with us on LinkedIn and X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241104090881/en/
Investor Relations & Media Inquiries Louise Wilkie
ir@sangamo.com media@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
過去 株価チャート
から 11 2024 まで 12 2024
Sangamo Therapeutics (NASDAQ:SGMO)
過去 株価チャート
から 12 2023 まで 12 2024